Introduction
The intravenous infusion of oxytocin is now widely accepted as an effective and safe method of inducing labour even when administered on a rapid titration basis. Recently it has been reported that the infusion of prostaglandin E. is also effective in inducing labour Embrey, 1970; Karim et al., 1970) . Karim et al. (1970) succeeded in inducing labour in each of 50 patients by using a continuous infusion of 0-5 jig/min. Embrey (1970) , who used doses of 0-5-6-0 Fg/min, had two failures in a series of 25 inductions. In some women oxytocin administration may fail to induce labour, especially when the membranes remain intact. This fact prompted us to compare the effectiveness of prostaglandin E, with that of the synthetic oxytocin, Syntocinon, in inducing labour.
Patients and Methods
The patients who participated in this study required induction at or near term for various reasons. They were selected at random into two groups according to whether their case record ended in an odd or an even number, one group receiving oxytocin and the other prostaglandin E,. Those The infusion rates were adjusted so that contractions occurred optimally every two to three minutes and lasted [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] seconds, and the infusion was maintained until delivery in each instance. Uterine contractions and fetal heart recordings were monitored continuously throughout labour with a Hewlett Packard cardiotocograph. Baseline recordings were obtained for at least 15 minutes before the start of infusion. During the induction of labour the membranes were ruptured artificially only in those cases of suspected fetal distress, as determined by fetal heart variations of more than 30 minutes' duration. In these subjects fetal blood samples were taken and they were subsequently eliminated from the final analysis. This was made on 30 patients, 15 in each group.
The essential criterion chosen to indicate successful induction was dilatation of the cervix. Since both primigravid and multigravid patients were studied it was decided to regard an increase in dilatation over that present before the onset of infusion as evidence of success rather than cervical dilatation of a certain arbitrary degree. Failure was considered to have occurred if there was no change over a 12-hour period. In this event the infusion was stopped, the patient was allowed to rest for the night, and other plans were made to effect delivery the next day. If progress had occurred infuLsions were kept running until delivery, maintaining contractions at the optimum rate and duration. Vaginal examinations were performed every four hours by one observer in each case. The degree of cervical dilatation was noted on each occasion though consideration was not given to changes in the length of the cervical canal.
Before the infusion was started each subject had an epidural catheter inserted. Bupivacaine 0 5% was later given at intervals as required, ensuring a standard method of analgesia and facilitating accurate recording of contractions and fetal heart rate by the external cardiotocograph. The times of alteration in the infusion rate were recorded, ensuring knowledge of the total quantity of each agent used. The times of onset of spontaneous membrane rupture and full dilatation were noted, as was the presence of any maternal cardiovascular or gastrointestinal side effects. Fetal well-being was assessed by Apgar scores taken at one and five minutes. At the conclusion of the study an attempt was made to correlate the Apgar score and the occurrence of type 2 decelerations in fetal heart rate recorded on the cardiotocograph with the agent used.
TITRATION SCHEDULES
Oxytocin.-The regimen used was that described by Turnbull and Anderson (1968 The infusion rate was started at 0-5 ,ug/min for 30 minutes, then increased every 15 minutes until optimum uterine activity occurred through the following dose range: 0 75, 1.0, 1-5, 2-0, 3 0, to a maximum concentration of 4.0 ,sg/min.
Results
The results of the administration of intravenous oxytocin and prostaglandin E, are shown in Tables I and II respectively. It is seen from Table I that 9 (60VO ) of the 15 patients receiving oxytocin had evidence of cervical dilatation within 12 hours. The mean induction-full dilatation interval was 8 hours 23 minutes. Of those that failed Case 3 had tense membranes at the conclusion of the infusion and then delivered rapidly after their rupture, and Cases 6, 18, and 28 had optimum uterine activity as recorded on the tocograph with low concentrations of oxytocin. Case 12 had short episodes when the frequency of contractions was not optimum even with the maximum concentration of 128 mU/min, and Case 29 had contractions of optimum frequency but rather low amplitude with the same dose. All except one of the failures (Case 29) required regular analgesia for discomfort. There was no correlation between parity and response, for two out of the five primigravid patients and four out of 10 multigravid patients failed. By using this titration regimen an early uterine response was produced in all instances, and contractions occurring with a frequency of once every three minutes first occurred within 30-60 minutes in all but two patients. Cases 6 and 29 took 90 minutes to achieve this frequency. Of the successes Cases, 8, 9, and 26 had little or no changes in cervical dilatation for six to eight hours. Fetal heart decelerations suggestive of fetal distress were recorded in two patients, but only one infant had an Apgar score of 5 or less at one minute. All were normal at five minutes.
It is seen from Table II that dilatation of the cervix was produced in all 15 patients receiving prostaglandin E2. The mean induction-full dilatation interval was 9 hours 55 minutes. Despite this success rate, however, Cases 7, 19, 23, 24, and 25 had little or no change in cervical dilatation for many hours before spontaneous rupture of the membranes, despite optimum uterine activity. Case 11 had no dilatation for eight hours and then subsequent rapid progress to full dilatation occurred with the membranes intact. Type 2 decelerations in fetal heart recordings were noted in a greater number of subjects, and two infants had an Apgar score of less than 5 at one minute. In retrospect fetal blood sampling should have been performed in Case 11. The low Apgar score at five minutes was associated with a low pH of a cord blood sample, but in other instances there was no obvious correlation between fetal heart decelerations and pH values of fetal scalp or cord blood.
One further patient, not considered in this analysis because artificial rupture of the membranes was subsequently performed, About half of the subjects receiving prosaglandin E, vomited during the course of labour and many experienced soreness and erythema along the course of the venous drainage from the infusion site. There were no instances of cardiovascular disturbance. By using the titration regimen described above an early uterine response occurred within 60 minutes, but direct comparison could not be made between the two groups about when the onset of effective contractions had started. The tocograph tracings showed that oxytocin produced an early uterine response with regula contractions of similar amplitude. However, it generally took prostglandin E, longer to induce a similar pattern of contractions, the initial uterine response being contractions of varying amplitude and frequency suggesting an initial "irritable" state.
We are unable to exclude for certain whether any significant degree of uterine hypertonus occurred in this study, for an external tocograph rather than an intrauterine recording device was used. Nevertheless, in three subjects there were episodes when the tracing was deflected by a contraction from the baseline for more than five minutes, within 90 minutes of the start of the infusion, but there was no significant effect on the fetal heart rate at the time. Two (Cases 10 and 11) were receiving 0 5 and 10 Ftg of prostaglandin E./min respectively, and the other (Case 6) 16 mU of oxytocin/min. In the former the deflections did not recur despite the continuation of therapy at the same infusion rate, though fetal heart recordings later became abnormal, and definite fetal distress was present in one. In the subject receiving oxytocin the finding did not recur, though the infusion was temporarily reduced.
Discussion
In the only other study reported comparing the effectiveness of prostaglandin E, with oxytocin in the induction of labour, Beazley and Gillespie (1971) that prostaglandin E2 is more effective in inducing labour must be considered with caution, for though the patients were selected at random the groups were not identically matched. The differences found in these studies may be partly explained by essential differences in the plan of each investigation and the exact protocol undertaken. Beazley and Gillespie (1971) started the infusion of prostaglandin E, at 0-21 [Lg/min and oxytocin at 2 1 mU/min. These rates were doubled every hour until contractions were effective and then usually maintained at a fixed rate. In addition some patients' membranes were ruptured artificially when labour was established. Our approach was basically different in that rapid titration regimens were used to induce an early onset of regular contractions in each group, as we considered it was impossible to know that the stimulatory effect of doubling the infusion rates of prostaglandin E2 was quantitatively equivalent to doing the same with oxytocin. It is therefore not surprising that the results were different.
By using the titration regimens an initial uterine response occurred at a comparable time with both substances, though regular contractions of similar amplitude generally occurred earlier with oxytocin. Despite this fact prostaglandin E2 was more effective in dilating the cervix, and it is our impression that this substance had a greater stimulatory effect on the uterus than oxytocin in the dose range used. One feature tending to confirm this impression was the finding that while prostaglandin E2 invariably resulted in spontaneous rupture of the membranes, this occurred before dilatation of the cervix had reached 6 cm in eight out of 15 patients. With oxytocin this was so in only two out of the nine successes. With both agents basically two types of response were elicited. One resembled normal labour in that progressive cervical dilatation occurred with time, while in the other little or no change in dilatation resulted for many hours, usually until the onset of spontaneous membrane rupture. About one-third of the successes in each group were in this latter category.
With regard to the practicality of using oxytocin to induce labour in the presence of intact membranes, we feel that a greater success rate could probably be achieved if the infusion rate were increased above that required to induce contractions which appear "optimum" on an external tocograph. In effect oxytocin titration would be against cervical dilatation rather than contractions. The limitation of such a policy is a possibility of causing uterine hypertonus, though Francis et al. (1970) did not demonstrate this in their series of 130 inductions with oxytocin infusions in doses ranging from 2 to 128 mU/min. We feel, however, that there are possible dangers of pursuing a similar policy of increasing the dose of prostaglandins above that required to induce optimum contractions. Besides maternal disturbance caused by possible vomiting and soreness of the arm it is our impression that fetal distress may be provoked, for contractions of excessive frequency or strength may result or uterine hypertonus may occur, as recently reported by Roberts and Turnbull (1971) .
In this study the necessity for performing fetal blood sampling to establish the significance of fetal heart variations was noticeably different in the two groups, though a pH of <7-20 was found in only one instance. It is possible that these findings could have been minimized had the infusion rates been reduced after spontaneous rupture of the membranes. This occurred at an early stage of cervical dilatation in five out of the six subjects suspected of having fetal distress. Besides the alteration in uterine activity known to follow membrane rupture, it is possible that prostaglandins have an augmented effect on the uterus itself through vaginal absorption of prostaglandins known to be present in liquor during labour (Karim and Devlin, 1967) .
Since prostaglandin E. has a profound stimulatory effect on the uterus we feel that a detailed study of the effects of different dose levels on the metabolic and biochemical status of the fetus should be evaluated before their widespread introduction into clinical obstetric practice.
